ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Azilsartan Medoxomil API Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-32U7559
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Azilsartan Medoxomil API Market Research Report 2022
BUY CHAPTERS

Global Azilsartan Medoxomil API Market Research Report 2025

Code: QYRE-Auto-32U7559
Report
March 2025
Pages:96
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Metrochem API
Takeda
Lupin Ltd
Acura Labs
Jubilant Pharma
HEC Pharm
CTX Life Sciences
Valiant
Zhejiang Hongyuan
Honour Lab
Enomark
Zhejiang Tianyu
Zhuhai Rundu

Azilsartan Medoxomil API Market Size

The global market for Azilsartan Medoxomil API was valued at US$ 22 million in the year 2024 and is projected to reach a revised size of US$ 77.5 million by 2031, growing at a CAGR of 20.0% during the forecast period.

Azilsartan Medoxomil API Market

Azilsartan Medoxomil API Market

Azilsartan medoxomil (trade name Edarb) is an angiotensin II receptor blocker (ARB) that lowers blood pressure by blocking the action of angiotensin II, a vasopressor hormone. It is indicated for the treatment of hypertension to lower blood pressure which reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. Azilsartan medoxomil may be used either alone or in combination with other antihypertensive agents such as chlorthalidone (CLD). As an ARB, azilsartan medoxomil selectively inhibits angiotensin II from binding to the angiotensin II type-1 receptor (AT1). This receptor inhibition provides the antihypertensive activity of azilsartan medoxomil because it blocks the pressor effects of angiotensin II. Azilsartan medoxomil is a prodrug of azilsartan. It is hydrolyzed to the active moiety, azilsartan, in the gastrointestinal (GI) tract during the absorption phase.
Main manufacturers of global azilsartan medoxomil API market are Takeda, Metrochem API and Jubilant Pharma. Takeda and Metrochem API are the top 2 players and accounts for over 40% of global market share in total. Geographically speaking, USA is the largest market and covers about 30% of total market share, followed by Europe with 20%. In terms of application, 40 mg Tablets holds an important market share of over 50%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Azilsartan Medoxomil API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Azilsartan Medoxomil API.
The Azilsartan Medoxomil API market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Azilsartan Medoxomil API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Azilsartan Medoxomil API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Azilsartan Medoxomil API Market Report

Report Metric Details
Report Name Azilsartan Medoxomil API Market
Accounted market size in year US$ 22 million
Forecasted market size in 2031 US$ 77.5 million
CAGR 20.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • 0.99
  • Others
Segment by Application
  • 20 mg Tablets
  • 40 mg Tablets
  • 80 mg Tablets
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Takeda, Lupin, Acura Labs, Metrochem API, Jubilant Pharma, Zhejiang Hongyuan, Honour Lab, HEC Pharm, Enomark, CTX Life Sciences, Zhejiang Tianyu, Zhuhai Rundu, Valiant Co
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Azilsartan Medoxomil API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Azilsartan Medoxomil API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Azilsartan Medoxomil API Market growing?

Ans: The Azilsartan Medoxomil API Market witnessing a CAGR of 20.0% during the forecast period 2025-2031.

What is the Azilsartan Medoxomil API Market size in 2031?

Ans: The Azilsartan Medoxomil API Market size in 2031 will be US$ 77.5 million.

What is the market share of major companies in Azilsartan Medoxomil API Market?

Ans: Takeda and Metrochem API are the top 2 players and accounts for over 40% of global market share in total.

What is the Azilsartan Medoxomil API Market share by region?

Ans: Geographically speaking, USA is the largest market and covers about 30% of total market share, followed by Europe with 20%.

What is the Azilsartan Medoxomil API Market share by application?

Ans: In terms of application, 40 mg Tablets holds an important market share of over 50%.

Who are the main players in the Azilsartan Medoxomil API Market report?

Ans: The main players in the Azilsartan Medoxomil API Market are Takeda, Lupin, Acura Labs, Metrochem API, Jubilant Pharma, Zhejiang Hongyuan, Honour Lab, HEC Pharm, Enomark, CTX Life Sciences, Zhejiang Tianyu, Zhuhai Rundu, Valiant Co

What are the Application segmentation covered in the Azilsartan Medoxomil API Market report?

Ans: The Applications covered in the Azilsartan Medoxomil API Market report are 20 mg Tablets, 40 mg Tablets, 80 mg Tablets

What are the Type segmentation covered in the Azilsartan Medoxomil API Market report?

Ans: The Types covered in the Azilsartan Medoxomil API Market report are 0.99, Others

Recommended Reports

Angiotensin Receptor Blockers

Antihypertensive APIs

Cardiovascular Drug APIs

Market trends :

Topic Trends
Global the global azilsartan medoxomil api market is experiencing rapid growth driven by increased demand for antihypertensive therapies and expanding adoption of 40 mg tablet formulations.
Type 0.99 - the 0.99 purity type remains the standard in the market, supporting consistent quality and regulatory compliance for azilsartan medoxomil api.
Application 40 mg Tablets - 40 mg tablets dominate market demand, accounting for over half of global consumption due to clinical preference and prescribing patterns.
Company Takeda - takeda maintains a leading position in the azilsartan medoxomil api market through sustained product availability and strong distribution networks.
Metrochem API - metrochem api strengthens its market share by focusing on high-quality manufacturing and expanding supply capabilities for azilsartan medoxomil api.
Region North America - north america, led by the usa, is the largest regional market for azilsartan medoxomil api, driven by high prevalence of hypertension and established healthcare infrastructure.
EMEA - europe maintains strong demand for azilsartan medoxomil api, supported by widespread adoption in cardiovascular treatment protocols.
APAC - apac region sees rising demand for azilsartan medoxomil api, particularly in china and india, due to increasing hypertension rates and expanding pharmaceutical manufacturing.
1 Azilsartan Medoxomil API Market Overview
1.1 Product Definition
1.2 Azilsartan Medoxomil API by Type
1.2.1 Global Azilsartan Medoxomil API Market Value Comparison by Type (2024 VS 2031)
1.2.2 0.99
1.2.3 Others
1.3 Azilsartan Medoxomil API by Application
1.3.1 Global Azilsartan Medoxomil API Market Value by Application (2024 VS 2031)
1.3.2 20 mg Tablets
1.3.3 40 mg Tablets
1.3.4 80 mg Tablets
1.4 Global Azilsartan Medoxomil API Market Size Estimates and Forecasts
1.4.1 Global Azilsartan Medoxomil API Revenue 2020-2031
1.4.2 Global Azilsartan Medoxomil API Sales 2020-2031
1.4.3 Global Azilsartan Medoxomil API Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Azilsartan Medoxomil API Market Competition by Manufacturers
2.1 Global Azilsartan Medoxomil API Sales Market Share by Manufacturers (2020-2025)
2.2 Global Azilsartan Medoxomil API Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Azilsartan Medoxomil API Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Azilsartan Medoxomil API, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Azilsartan Medoxomil API, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Azilsartan Medoxomil API, Product Type & Application
2.7 Global Key Manufacturers of Azilsartan Medoxomil API, Date of Enter into This Industry
2.8 Global Azilsartan Medoxomil API Market Competitive Situation and Trends
2.8.1 Global Azilsartan Medoxomil API Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Azilsartan Medoxomil API Players Market Share by Revenue
2.8.3 Global Azilsartan Medoxomil API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Azilsartan Medoxomil API Market Scenario by Region
3.1 Global Azilsartan Medoxomil API Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Azilsartan Medoxomil API Sales by Region: 2020-2031
3.2.1 Global Azilsartan Medoxomil API Sales by Region: 2020-2025
3.2.2 Global Azilsartan Medoxomil API Sales by Region: 2026-2031
3.3 Global Azilsartan Medoxomil API Revenue by Region: 2020-2031
3.3.1 Global Azilsartan Medoxomil API Revenue by Region: 2020-2025
3.3.2 Global Azilsartan Medoxomil API Revenue by Region: 2026-2031
3.4 North America Azilsartan Medoxomil API Market Facts & Figures by Country
3.4.1 North America Azilsartan Medoxomil API Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Azilsartan Medoxomil API Sales by Country (2020-2031)
3.4.3 North America Azilsartan Medoxomil API Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Azilsartan Medoxomil API Market Facts & Figures by Country
3.5.1 Europe Azilsartan Medoxomil API Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Azilsartan Medoxomil API Sales by Country (2020-2031)
3.5.3 Europe Azilsartan Medoxomil API Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Azilsartan Medoxomil API Market Facts & Figures by Region
3.6.1 Asia Pacific Azilsartan Medoxomil API Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Azilsartan Medoxomil API Sales by Region (2020-2031)
3.6.3 Asia Pacific Azilsartan Medoxomil API Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Azilsartan Medoxomil API Market Facts & Figures by Country
3.7.1 Latin America Azilsartan Medoxomil API Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Azilsartan Medoxomil API Sales by Country (2020-2031)
3.7.3 Latin America Azilsartan Medoxomil API Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Azilsartan Medoxomil API Market Facts & Figures by Country
3.8.1 Middle East and Africa Azilsartan Medoxomil API Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Azilsartan Medoxomil API Sales by Country (2020-2031)
3.8.3 Middle East and Africa Azilsartan Medoxomil API Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Azilsartan Medoxomil API Sales by Type (2020-2031)
4.1.1 Global Azilsartan Medoxomil API Sales by Type (2020-2025)
4.1.2 Global Azilsartan Medoxomil API Sales by Type (2026-2031)
4.1.3 Global Azilsartan Medoxomil API Sales Market Share by Type (2020-2031)
4.2 Global Azilsartan Medoxomil API Revenue by Type (2020-2031)
4.2.1 Global Azilsartan Medoxomil API Revenue by Type (2020-2025)
4.2.2 Global Azilsartan Medoxomil API Revenue by Type (2026-2031)
4.2.3 Global Azilsartan Medoxomil API Revenue Market Share by Type (2020-2031)
4.3 Global Azilsartan Medoxomil API Price by Type (2020-2031)
5 Segment by Application
5.1 Global Azilsartan Medoxomil API Sales by Application (2020-2031)
5.1.1 Global Azilsartan Medoxomil API Sales by Application (2020-2025)
5.1.2 Global Azilsartan Medoxomil API Sales by Application (2026-2031)
5.1.3 Global Azilsartan Medoxomil API Sales Market Share by Application (2020-2031)
5.2 Global Azilsartan Medoxomil API Revenue by Application (2020-2031)
5.2.1 Global Azilsartan Medoxomil API Revenue by Application (2020-2025)
5.2.2 Global Azilsartan Medoxomil API Revenue by Application (2026-2031)
5.2.3 Global Azilsartan Medoxomil API Revenue Market Share by Application (2020-2031)
5.3 Global Azilsartan Medoxomil API Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Takeda
6.1.1 Takeda Company Information
6.1.2 Takeda Description and Business Overview
6.1.3 Takeda Azilsartan Medoxomil API Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Takeda Azilsartan Medoxomil API Product Portfolio
6.1.5 Takeda Recent Developments/Updates
6.2 Lupin
6.2.1 Lupin Company Information
6.2.2 Lupin Description and Business Overview
6.2.3 Lupin Azilsartan Medoxomil API Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Lupin Azilsartan Medoxomil API Product Portfolio
6.2.5 Lupin Recent Developments/Updates
6.3 Acura Labs
6.3.1 Acura Labs Company Information
6.3.2 Acura Labs Description and Business Overview
6.3.3 Acura Labs Azilsartan Medoxomil API Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Acura Labs Azilsartan Medoxomil API Product Portfolio
6.3.5 Acura Labs Recent Developments/Updates
6.4 Metrochem API
6.4.1 Metrochem API Company Information
6.4.2 Metrochem API Description and Business Overview
6.4.3 Metrochem API Azilsartan Medoxomil API Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Metrochem API Azilsartan Medoxomil API Product Portfolio
6.4.5 Metrochem API Recent Developments/Updates
6.5 Jubilant Pharma
6.5.1 Jubilant Pharma Company Information
6.5.2 Jubilant Pharma Description and Business Overview
6.5.3 Jubilant Pharma Azilsartan Medoxomil API Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Jubilant Pharma Azilsartan Medoxomil API Product Portfolio
6.5.5 Jubilant Pharma Recent Developments/Updates
6.6 Zhejiang Hongyuan
6.6.1 Zhejiang Hongyuan Company Information
6.6.2 Zhejiang Hongyuan Description and Business Overview
6.6.3 Zhejiang Hongyuan Azilsartan Medoxomil API Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Zhejiang Hongyuan Azilsartan Medoxomil API Product Portfolio
6.6.5 Zhejiang Hongyuan Recent Developments/Updates
6.7 Honour Lab
6.7.1 Honour Lab Company Information
6.7.2 Honour Lab Description and Business Overview
6.7.3 Honour Lab Azilsartan Medoxomil API Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Honour Lab Azilsartan Medoxomil API Product Portfolio
6.7.5 Honour Lab Recent Developments/Updates
6.8 HEC Pharm
6.8.1 HEC Pharm Company Information
6.8.2 HEC Pharm Description and Business Overview
6.8.3 HEC Pharm Azilsartan Medoxomil API Sales, Revenue and Gross Margin (2020-2025)
6.8.4 HEC Pharm Azilsartan Medoxomil API Product Portfolio
6.8.5 HEC Pharm Recent Developments/Updates
6.9 Enomark
6.9.1 Enomark Company Information
6.9.2 Enomark Description and Business Overview
6.9.3 Enomark Azilsartan Medoxomil API Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Enomark Azilsartan Medoxomil API Product Portfolio
6.9.5 Enomark Recent Developments/Updates
6.10 CTX Life Sciences
6.10.1 CTX Life Sciences Company Information
6.10.2 CTX Life Sciences Description and Business Overview
6.10.3 CTX Life Sciences Azilsartan Medoxomil API Sales, Revenue and Gross Margin (2020-2025)
6.10.4 CTX Life Sciences Azilsartan Medoxomil API Product Portfolio
6.10.5 CTX Life Sciences Recent Developments/Updates
6.11 Zhejiang Tianyu
6.11.1 Zhejiang Tianyu Company Information
6.11.2 Zhejiang Tianyu Description and Business Overview
6.11.3 Zhejiang Tianyu Azilsartan Medoxomil API Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Zhejiang Tianyu Azilsartan Medoxomil API Product Portfolio
6.11.5 Zhejiang Tianyu Recent Developments/Updates
6.12 Zhuhai Rundu
6.12.1 Zhuhai Rundu Company Information
6.12.2 Zhuhai Rundu Description and Business Overview
6.12.3 Zhuhai Rundu Azilsartan Medoxomil API Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Zhuhai Rundu Azilsartan Medoxomil API Product Portfolio
6.12.5 Zhuhai Rundu Recent Developments/Updates
6.13 Valiant Co
6.13.1 Valiant Co Company Information
6.13.2 Valiant Co Description and Business Overview
6.13.3 Valiant Co Azilsartan Medoxomil API Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Valiant Co Azilsartan Medoxomil API Product Portfolio
6.13.5 Valiant Co Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Azilsartan Medoxomil API Industry Chain Analysis
7.2 Azilsartan Medoxomil API Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Azilsartan Medoxomil API Production Mode & Process Analysis
7.4 Azilsartan Medoxomil API Sales and Marketing
7.4.1 Azilsartan Medoxomil API Sales Channels
7.4.2 Azilsartan Medoxomil API Distributors
7.5 Azilsartan Medoxomil API Customer Analysis
8 Azilsartan Medoxomil API Market Dynamics
8.1 Azilsartan Medoxomil API Industry Trends
8.2 Azilsartan Medoxomil API Market Drivers
8.3 Azilsartan Medoxomil API Market Challenges
8.4 Azilsartan Medoxomil API Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Metrochem API
Takeda
Lupin Ltd
Acura Labs
Jubilant Pharma
HEC Pharm
CTX Life Sciences
Valiant
Zhejiang Hongyuan
Honour Lab
Enomark
Zhejiang Tianyu
Zhuhai Rundu
List of Tables
 Table 1. Global Azilsartan Medoxomil API Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Azilsartan Medoxomil API Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Azilsartan Medoxomil API Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Azilsartan Medoxomil API Sales (Kg) of Key Manufacturers (2020-2025)
 Table 5. Global Azilsartan Medoxomil API Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Azilsartan Medoxomil API Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Azilsartan Medoxomil API Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Azilsartan Medoxomil API Average Price (USD/Kg) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Azilsartan Medoxomil API, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Azilsartan Medoxomil API, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Azilsartan Medoxomil API, Product Type & Application
 Table 12. Global Key Manufacturers of Azilsartan Medoxomil API, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Azilsartan Medoxomil API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Azilsartan Medoxomil API as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Azilsartan Medoxomil API Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Azilsartan Medoxomil API Sales by Region (2020-2025) & (Kg)
 Table 18. Global Azilsartan Medoxomil API Sales Market Share by Region (2020-2025)
 Table 19. Global Azilsartan Medoxomil API Sales by Region (2026-2031) & (Kg)
 Table 20. Global Azilsartan Medoxomil API Sales Market Share by Region (2026-2031)
 Table 21. Global Azilsartan Medoxomil API Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Azilsartan Medoxomil API Revenue Market Share by Region (2020-2025)
 Table 23. Global Azilsartan Medoxomil API Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Azilsartan Medoxomil API Revenue Market Share by Region (2026-2031)
 Table 25. North America Azilsartan Medoxomil API Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Azilsartan Medoxomil API Sales by Country (2020-2025) & (Kg)
 Table 27. North America Azilsartan Medoxomil API Sales by Country (2026-2031) & (Kg)
 Table 28. North America Azilsartan Medoxomil API Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Azilsartan Medoxomil API Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Azilsartan Medoxomil API Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Azilsartan Medoxomil API Sales by Country (2020-2025) & (Kg)
 Table 32. Europe Azilsartan Medoxomil API Sales by Country (2026-2031) & (Kg)
 Table 33. Europe Azilsartan Medoxomil API Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Azilsartan Medoxomil API Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Azilsartan Medoxomil API Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Azilsartan Medoxomil API Sales by Region (2020-2025) & (Kg)
 Table 37. Asia Pacific Azilsartan Medoxomil API Sales by Region (2026-2031) & (Kg)
 Table 38. Asia Pacific Azilsartan Medoxomil API Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Azilsartan Medoxomil API Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Azilsartan Medoxomil API Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Azilsartan Medoxomil API Sales by Country (2020-2025) & (Kg)
 Table 42. Latin America Azilsartan Medoxomil API Sales by Country (2026-2031) & (Kg)
 Table 43. Latin America Azilsartan Medoxomil API Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Azilsartan Medoxomil API Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Azilsartan Medoxomil API Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Azilsartan Medoxomil API Sales by Country (2020-2025) & (Kg)
 Table 47. Middle East and Africa Azilsartan Medoxomil API Sales by Country (2026-2031) & (Kg)
 Table 48. Middle East and Africa Azilsartan Medoxomil API Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Azilsartan Medoxomil API Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Azilsartan Medoxomil API Sales (Kg) by Type (2020-2025)
 Table 51. Global Azilsartan Medoxomil API Sales (Kg) by Type (2026-2031)
 Table 52. Global Azilsartan Medoxomil API Sales Market Share by Type (2020-2025)
 Table 53. Global Azilsartan Medoxomil API Sales Market Share by Type (2026-2031)
 Table 54. Global Azilsartan Medoxomil API Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Azilsartan Medoxomil API Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Azilsartan Medoxomil API Revenue Market Share by Type (2020-2025)
 Table 57. Global Azilsartan Medoxomil API Revenue Market Share by Type (2026-2031)
 Table 58. Global Azilsartan Medoxomil API Price (USD/Kg) by Type (2020-2025)
 Table 59. Global Azilsartan Medoxomil API Price (USD/Kg) by Type (2026-2031)
 Table 60. Global Azilsartan Medoxomil API Sales (Kg) by Application (2020-2025)
 Table 61. Global Azilsartan Medoxomil API Sales (Kg) by Application (2026-2031)
 Table 62. Global Azilsartan Medoxomil API Sales Market Share by Application (2020-2025)
 Table 63. Global Azilsartan Medoxomil API Sales Market Share by Application (2026-2031)
 Table 64. Global Azilsartan Medoxomil API Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Azilsartan Medoxomil API Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Azilsartan Medoxomil API Revenue Market Share by Application (2020-2025)
 Table 67. Global Azilsartan Medoxomil API Revenue Market Share by Application (2026-2031)
 Table 68. Global Azilsartan Medoxomil API Price (USD/Kg) by Application (2020-2025)
 Table 69. Global Azilsartan Medoxomil API Price (USD/Kg) by Application (2026-2031)
 Table 70. Takeda Company Information
 Table 71. Takeda Description and Business Overview
 Table 72. Takeda Azilsartan Medoxomil API Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 73. Takeda Azilsartan Medoxomil API Product
 Table 74. Takeda Recent Developments/Updates
 Table 75. Lupin Company Information
 Table 76. Lupin Description and Business Overview
 Table 77. Lupin Azilsartan Medoxomil API Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 78. Lupin Azilsartan Medoxomil API Product
 Table 79. Lupin Recent Developments/Updates
 Table 80. Acura Labs Company Information
 Table 81. Acura Labs Description and Business Overview
 Table 82. Acura Labs Azilsartan Medoxomil API Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 83. Acura Labs Azilsartan Medoxomil API Product
 Table 84. Acura Labs Recent Developments/Updates
 Table 85. Metrochem API Company Information
 Table 86. Metrochem API Description and Business Overview
 Table 87. Metrochem API Azilsartan Medoxomil API Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 88. Metrochem API Azilsartan Medoxomil API Product
 Table 89. Metrochem API Recent Developments/Updates
 Table 90. Jubilant Pharma Company Information
 Table 91. Jubilant Pharma Description and Business Overview
 Table 92. Jubilant Pharma Azilsartan Medoxomil API Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 93. Jubilant Pharma Azilsartan Medoxomil API Product
 Table 94. Jubilant Pharma Recent Developments/Updates
 Table 95. Zhejiang Hongyuan Company Information
 Table 96. Zhejiang Hongyuan Description and Business Overview
 Table 97. Zhejiang Hongyuan Azilsartan Medoxomil API Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 98. Zhejiang Hongyuan Azilsartan Medoxomil API Product
 Table 99. Zhejiang Hongyuan Recent Developments/Updates
 Table 100. Honour Lab Company Information
 Table 101. Honour Lab Description and Business Overview
 Table 102. Honour Lab Azilsartan Medoxomil API Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 103. Honour Lab Azilsartan Medoxomil API Product
 Table 104. Honour Lab Recent Developments/Updates
 Table 105. HEC Pharm Company Information
 Table 106. HEC Pharm Description and Business Overview
 Table 107. HEC Pharm Azilsartan Medoxomil API Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 108. HEC Pharm Azilsartan Medoxomil API Product
 Table 109. HEC Pharm Recent Developments/Updates
 Table 110. Enomark Company Information
 Table 111. Enomark Description and Business Overview
 Table 112. Enomark Azilsartan Medoxomil API Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 113. Enomark Azilsartan Medoxomil API Product
 Table 114. Enomark Recent Developments/Updates
 Table 115. CTX Life Sciences Company Information
 Table 116. CTX Life Sciences Description and Business Overview
 Table 117. CTX Life Sciences Azilsartan Medoxomil API Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 118. CTX Life Sciences Azilsartan Medoxomil API Product
 Table 119. CTX Life Sciences Recent Developments/Updates
 Table 120. Zhejiang Tianyu Company Information
 Table 121. Zhejiang Tianyu Description and Business Overview
 Table 122. Zhejiang Tianyu Azilsartan Medoxomil API Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 123. Zhejiang Tianyu Azilsartan Medoxomil API Product
 Table 124. Zhejiang Tianyu Recent Developments/Updates
 Table 125. Zhuhai Rundu Company Information
 Table 126. Zhuhai Rundu Description and Business Overview
 Table 127. Zhuhai Rundu Azilsartan Medoxomil API Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 128. Zhuhai Rundu Azilsartan Medoxomil API Product
 Table 129. Zhuhai Rundu Recent Developments/Updates
 Table 130. Valiant Co Company Information
 Table 131. Valiant Co Description and Business Overview
 Table 132. Valiant Co Azilsartan Medoxomil API Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 133. Valiant Co Azilsartan Medoxomil API Product
 Table 134. Valiant Co Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Azilsartan Medoxomil API Distributors List
 Table 138. Azilsartan Medoxomil API Customers List
 Table 139. Azilsartan Medoxomil API Market Trends
 Table 140. Azilsartan Medoxomil API Market Drivers
 Table 141. Azilsartan Medoxomil API Market Challenges
 Table 142. Azilsartan Medoxomil API Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Azilsartan Medoxomil API
 Figure 2. Global Azilsartan Medoxomil API Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Azilsartan Medoxomil API Market Share by Type: 2024 & 2031
 Figure 4. 0.99 Product Picture
 Figure 5. Others Product Picture
 Figure 6. Global Azilsartan Medoxomil API Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Azilsartan Medoxomil API Market Share by Application: 2024 & 2031
 Figure 8. 20 mg Tablets
 Figure 9. 40 mg Tablets
 Figure 10. 80 mg Tablets
 Figure 11. Global Azilsartan Medoxomil API Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Azilsartan Medoxomil API Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Azilsartan Medoxomil API Sales (2020-2031) & (Kg)
 Figure 14. Global Azilsartan Medoxomil API Average Price (USD/Kg) & (2020-2031)
 Figure 15. Azilsartan Medoxomil API Report Years Considered
 Figure 16. Azilsartan Medoxomil API Sales Share by Manufacturers in 2024
 Figure 17. Global Azilsartan Medoxomil API Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Azilsartan Medoxomil API Players: Market Share by Revenue in Azilsartan Medoxomil API in 2024
 Figure 19. Azilsartan Medoxomil API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Azilsartan Medoxomil API Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Azilsartan Medoxomil API Sales Market Share by Country (2020-2031)
 Figure 22. North America Azilsartan Medoxomil API Revenue Market Share by Country (2020-2031)
 Figure 23. United States Azilsartan Medoxomil API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Azilsartan Medoxomil API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Azilsartan Medoxomil API Sales Market Share by Country (2020-2031)
 Figure 26. Europe Azilsartan Medoxomil API Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Azilsartan Medoxomil API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Azilsartan Medoxomil API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Azilsartan Medoxomil API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Azilsartan Medoxomil API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Azilsartan Medoxomil API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Azilsartan Medoxomil API Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Azilsartan Medoxomil API Revenue Market Share by Region (2020-2031)
 Figure 34. China Azilsartan Medoxomil API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Azilsartan Medoxomil API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Azilsartan Medoxomil API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Azilsartan Medoxomil API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Azilsartan Medoxomil API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Azilsartan Medoxomil API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Azilsartan Medoxomil API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Azilsartan Medoxomil API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Azilsartan Medoxomil API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Azilsartan Medoxomil API Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Azilsartan Medoxomil API Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Azilsartan Medoxomil API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Azilsartan Medoxomil API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Azilsartan Medoxomil API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Azilsartan Medoxomil API Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Azilsartan Medoxomil API Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Azilsartan Medoxomil API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Azilsartan Medoxomil API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Azilsartan Medoxomil API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Azilsartan Medoxomil API by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Azilsartan Medoxomil API by Type (2020-2031)
 Figure 55. Global Azilsartan Medoxomil API Price (USD/Kg) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Azilsartan Medoxomil API by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Azilsartan Medoxomil API by Application (2020-2031)
 Figure 58. Global Azilsartan Medoxomil API Price (USD/Kg) by Application (2020-2031)
 Figure 59. Azilsartan Medoxomil API Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global Azilsartan Medoxomil Reagent Market Research Report 2024
Global Irbesartan Market Research Report 2024
Global N2 Trityl OlMesartan Acid Market Research Report 2024
Angiotensin Receptor Blockers ARBs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Valsartan Hydrochlorothiazide Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Azilsartan Medoxomil Potassium Market Research Report 2025
Angiotensin II Receptor Blocker ARBs API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Amlodipine and Olmesartan Market Insights Forecast to 2030
Global Irbesartan API Market Research Report 2024
Global Irbesartan Amlodipine Tablets Market Research Report 2024
Global Diuretic Azosemide Market Research Report 2024
Global AT1 Receptor Antagonists Market Research Report 2024
Global Irbesartan Tablets Market Insights Forecast to 2030
lrbesartan Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Valsartan Capsules Market Research Report 2024
Valsartan Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Sartan series Drugs Market Research Report 2024
Global Angiotensin II Type 1 Receptor AT1R Antagonists Market Research Report 2024
Global Azosemide API Market Research Report 2025
Global Olmesartan Medoxomil Hydrochlorothiazide Tablets Market Research Report 2024

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions